Integra upgraded by Citigroup with a new price target
Stocks in this Quantisnow insightHealth Care
Historical context for IART
Across the 13 sessions after earlier IART headlines, the stock closed higher 8 times and lower 5 times, with a median move of 2.2% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | IART | SPY |
|---|---|---|---|
| May 8, 2026 | Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference | +2.7% | +0.8% |
| May 5, 2026 | Integra LifeSciences Announces Leadership Transitionand 1 other headline that session | +24.1% | +0.8% |
| Apr 20, 2026 | Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026 | +0.2% | -0.2% |
| Apr 15, 2026 | Integra downgraded by Argus | -0.3% | +0.8% |
| Apr 7, 2026 | Integra LifeSciences Unveils New Real-World Evidence Highlighting PriMatrix® Utilization | +0.2% | +0.0% |
| Feb 26, 2026 | Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance | -2.2% | -0.6% |
Quantisnow market dataNASDAQ
IART
Integra LifeSciences Holdings Corporation
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
Get push alerts for IART
Full IART profile on Quantisnow Follow IART and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time